← Leaderboards
Paul Joseph Tesar
Case Western Reserve University
$9,717,238
Attributed
$14,330,644
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,330,644 · 11
By mechanism
R01$5,817,324 · 3
R35$4,401,448 · 1
R21$2,126,622 · 4
R33$1,647,577 · 2
R61$337,673 · 1
Top collaborators
- Robert H Miller11 shared
- Sanford D Markowitz5 shared
- Peter Christopher Scacheri5 shared
- Robert L Findling4 shared
- Martha Sherrill Windrem4 shared
- Yu Luo2 shared
- Xin Qi2 shared
- Wen-Quan Zou2 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Pierluigi Gambetti$33,097,698
- Qingzhong Kong$9,304,366
- Witold K Surewicz$20,523,800
- Neena Singh$9,545,188
- Wen-Quan Zou$3,109,259
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsIn VitroAdultMyelinationOligodendrogliaMyelinCell TypeNeuronsGeneticPreventFunctional DisorderMouse ModelInnovationMediatingCell LineIn VivoInduced Pluripotent Stem CellNeuraxisGenesInsightMultiple SclerosisImpaired CognitionBaseDisease Progression
Grant awards (37)
Modulating Glial Fate and Function in Development and Disease$683,922
R35 · FY2025 · NS · contact PI
Modulating Glial Fate and Function in Development and Disease$191,818
R35 · FY2025 · NS · contact PI
Modulating Glial Fate and Function in Development and Disease$663,404
R35 · FY2024 · NS · contact PI
Modulating Glial Fate and Function in Development and Disease$710,756
R35 · FY2023 · NS · contact PI
The role of gene enhancer elements in colon cancer$361,582
R01 · FY2023 · CA · contact PI
Modulating Glial Fate and Function in Development and Disease$764,422
R35 · FY2022 · NS · contact PI
Proteolipid protein suppression for Pelizaeus Merzbacher Disease$434,628
R33 · FY2022 · NS · contact PI
The role of gene enhancer elements in colon cancer$287,610
R01 · FY2022 · CA · contact PI
Modulating Glial Fate and Function in Development and Disease$683,922
R35 · FY2021 · NS · contact PI
Proteolipid protein suppression for Pelizaeus Merzbacher Disease$434,628
R33 · FY2021 · NS · contact PI
Modulating Glial Fate and Function in Development and Disease$53,666
R35 · FY2021 · NS · contact PI
Modulating glial fate and function in development and disease$649,538
R35 · FY2020 · NS · contact PI
Proteolipid protein suppression for Pelizaeus Merzbacher Disease$337,673
R61 · FY2020 · NS · contact PI
Drug-mediated enhancement of myelination$361,830
R01 · FY2019 · NS · contact PI
Human iPSC and glial chimeric modeling of Pelizaeus-Merzbacher Disease$371,793
R01 · FY2018 · NS · contact PI
Drug-mediated enhancement of myelination$359,245
R01 · FY2018 · NS · contact PI
Drug-mediated enhancement of myelination$374,888
R01 · FY2017 · NS · contact PI
Human iPSC and glial chimeric modeling of Pelizaeus-Merzbacher Disease$371,793
R01 · FY2017 · NS · contact PI
Drug-mediated enhancement of myelination$381,959
R01 · FY2016 · NS · contact PI
Human iPSC and glial chimeric modeling of Pelizaeus-Merzbacher Disease$371,220
R01 · FY2016 · NS · contact PI
Role of gene enhancer elements in colon cancer$296,923
R01 · FY2016 · CA
Drug-mediated enhancement of myelination$405,069
R01 · FY2015 · NS · contact PI
High throughput screening and in vivo testing of drugs to enhance remyelination$396,250
R21 · FY2015 · NS · contact PI
Human iPSC and glial chimeric modeling of Pelizaeus-Merzbacher Disease$389,819
R01 · FY2015 · NS · contact PI
Role of gene enhancer elements in colon cancer$312,166
R01 · FY2015 · CA
Generating iPSC-derived Neurons to Explore Formation & Inhibition of Human Prions$198,125
R21 · FY2015 · NS
High throughput screening and in vivo testing of drugs to enhance remyelination$396,250
R21 · FY2014 · NS · contact PI
Role of gene enhancer elements in colon cancer$394,819
R01 · FY2014 · CA
Generating iPSC-derived Neurons to Explore Formation & Inhibition of Human Prions$237,750
R21 · FY2014 · NS
Role of gene enhancer elements in colon cancer$382,609
R01 · FY2013 · CA
Role of gene enhancer elements in colon cancer$393,999
R01 · FY2012 · CA
Functional Comparison of Induced Pluripotent Stem Cell-Derived Oligodendrocytes i$386,388
R33 · FY2012 · MH · contact PI
Derivation and dopaminergic differentiation of human drug addict-specific iPS cel$235,500
R21 · FY2012 · DA · contact PI
Functional Comparison of Induced Pluripotent Stem Cell-Derived Oligodendrocytes i$391,933
R33 · FY2011 · MH
Derivation and dopaminergic differentiation of human drug addict-specific iPS cel$196,250
R21 · FY2011 · DA · contact PI
Functional Comparison of Induced Pluripotent Stem Cell-Derived Oligodendrocytes i$234,536
R21 · FY2010 · MH
Functional Comparison of Induced Pluripotent Stem Cell-Derived Oligodendrocytes i$231,961
R21 · FY2009 · MH